LLY:BCBA
Eli Lilly and Co CEDEAR
ARS 23,100.00
arrow_upward
+0.13%(+29.31) 1D
Jul 2, 3:11:24 PM GMT-3 · ARS
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY...
Mkt. cap
1.08T
Volume
0.00
No. of employees
50K
Mkt. cap
1.08T
Volume
0.00
No. of employees
50K
News stories
From web sources and news partners
Yahoo Finance
·
37 minutes ago
Eli Lilly's Obesity Data Support Broader Portfolio Beyond Tirzepatide, UBS Says
Benzinga
·
49 minutes ago
Why Is Foghorn Therapeutics Stock Tumbling Today? - Foghorn Therapeutics (NASDAQ:FHTX)
Trefis
·
1 hour ago
What Is The Options Market Telling Us About Eli Lilly Stock?
Investing.com
·
2 hours ago
BMO reiterates Eli Lilly stock Outperform on TRIUMPH-2 data
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly and Co CEDEAR
CEODavid A. Ricks
Employees50K
Founded1876
HeadquartersIndianapolis, Indiana, United States
SectorPharmaceutical industry
Websitelilly.com